clinical trials

Preliminary results released of Phase 1 clinical trial targeting mesothelin

Yesterday, at the annual meeting of the American Society of Gene and Cell Therapy in Chicago, researchers from Memorial Sloan Kettering Cancer Center released a preliminary report on their Phase 1 study into regionally delivered autologous mesothelin-targeted CAR T cells in patients with pleural mesothelioma.
Drs. Prasad Adusumilli, with co-authors Marjorie Zauderer, and Valerie Rusch (all […]


“There’s no question that research cures cancer”

“There’s no question that research cures cancer,” began Dr. Rich Alexander of the University of Maryland and chair of the Meso Foundation’s Board of Directors. “If you look at the most effective therapies that we have now for many cancers across the country, those treatments were defined through the clinical trials process.”
At the 2017 International […]


Best Wishes to Verastem in their New Endeavors in Cancer Research

Just today, we learned that Verastem, a biotech company that has previously done research in mesothelioma, has now embarked on several new projects.
In the news, announced in a press release, the company lists several projects, including this one:
Clinical Collaboration with Pfizer and Merck KGaA to Evaluate Combination of VS-6063 and Avelumab in Ovarian Cancer –In March […]


House Passes ’21st Century Cures’ Bill Today

Today, a bi-partisan bill called the “21st Century Cures,” which would add $8.5 billion of funding to the NIH’s budget, passed by a 344-77 vote in the House.
The bill seeks to “accelerate the discovery, development and delivery of life saving and life improving therapies, and transforms the quest for faster cures by:

Removing barriers to increased research […]


Examining Current Clinical Trials and Mesothelioma Treatment Trends

Watch Mary Hesdorffer, the Meso Foundation’s executive director and mesothelioma expert, in this opening presentation at the 2015 International Symposium on Malignant Mesothelioma. In this video, she discusses the state of mesothelioma research and treatment options. Her discussion begins with a focus on clinical trials. With 92 open clinical trials for mesothelioma, of which 55 […]